373 related articles for article (PubMed ID: 29424477)
21. Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque.
Sarlon-Bartoli G; Boudes A; Buffat C; Bartoli MA; Piercecchi-Marti MD; Sarlon E; Arnaud L; Bennis Y; Thevenin B; Squarcioni C; Nicoli F; Dignat-George F; Sabatier F; Magnan PE;
Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):154-9. PubMed ID: 22075154
[TBL] [Abstract][Full Text] [Related]
22. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
[TBL] [Abstract][Full Text] [Related]
23. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-associated phospholipase A
Garg PK; Norby FL; Polfus LM; Boerwinkle E; Gibbs RA; Grove ML; Folsom AR; Garimella PS; Matsushita K; Hoogeveen RC; Ballantyne CM
Atherosclerosis; 2018 Jan; 268():12-18. PubMed ID: 29169030
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.
Garg PK; Arnold AM; Hinckley Stukovsky KD; Koro C; Jenny NS; Mukamal KJ; Criqui MH; Furberg CD; Newman AB; Cushman M
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):750-6. PubMed ID: 26848158
[TBL] [Abstract][Full Text] [Related]
26. [Changes of serum lipoprotein-related phospholipase A2 in patients with white matter lesion based on KIM classification and its correlation with carotid atherosclerotic plaque].
Zhang W; Zhang YM; Li LL; Xia Y; Zhou X; Zhu XQ; Sun ZW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1130-1135. PubMed ID: 32311875
[No Abstract] [Full Text] [Related]
27. Lipoprotein-Associated Phospholipase A2 Activity and Mass as Independent Risk Factor of Stroke: A Meta-Analysis.
Hu G; Liu D; Tong H; Huang W; Hu Y; Huang Y
Biomed Res Int; 2019; 2019():8642784. PubMed ID: 31236414
[TBL] [Abstract][Full Text] [Related]
28. Relation between lipoprotein-associated phospholipase A
Zhou F; Liu Y; Shi H; Huang Q; Zhou J
Neurol Sci; 2018 Sep; 39(9):1591-1596. PubMed ID: 29938341
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein-associated phospholipase A
Garg PK; Jorgensen NW; McClelland RL; Jenny NS; Criqui MH; Allison MA; Greenland P; Rosenson RS; Siscovick DS; Cushman M
Vasc Med; 2017 Feb; 22(1):5-12. PubMed ID: 28215109
[TBL] [Abstract][Full Text] [Related]
30. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis.
Kolasa-Trela R; Fil K; Bazanek M; Grudzień G; Sobczyk D; Sadowski J; Undas A
Clin Chem Lab Med; 2012 Oct; 50(10):1825-31. PubMed ID: 23089713
[TBL] [Abstract][Full Text] [Related]
32. A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass.
Qi Y; Zhao D; Jia Z; Wang W; Wang M; Sun J; Liu J; Li Y; Xie W; Liu J
Sci Rep; 2016 Dec; 6():37465. PubMed ID: 27905470
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.
Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS
Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715
[TBL] [Abstract][Full Text] [Related]
34. Lp-PLA
Wang Y; Hu S; Ren L; Lei Z; Lan T; Cai J; Li C
Neurol Res; 2019 Jan; 41(1):1-8. PubMed ID: 30296199
[No Abstract] [Full Text] [Related]
35. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
36. Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke.
Zhang X; Liu L; Jiang N; Liu Y; Wang Q; Tang X; Zhai Q; Zhao L
BMC Neurol; 2022 Dec; 22(1):482. PubMed ID: 36517761
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
[TBL] [Abstract][Full Text] [Related]
38. Analysis of intima-media thickness of carotid artery and lipoprotein-associated phospholipase A2 in coronary heart diseases of different types.
Li Y
Technol Health Care; 2015; 23 Suppl 1():S147-50. PubMed ID: 26410317
[TBL] [Abstract][Full Text] [Related]
39. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
Zhang H; Gao Y; Wu D; Zhang D
BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis.
Song M; Li N; Yao Y; Wang K; Yang J; Cui Q; Geng B; Chen J; Wang Y; Cheng W; Zhou Y
J Cell Mol Med; 2019 Aug; 23(8):4970-4979. PubMed ID: 31240862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]